Inventor
CREW ANDREW P
US54 patents
⚠️ This page may combine multiple inventors who share the name “CREW ANDREW P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARVINAS OPERATIONS INC
38 patentsUS11236051B2Feb 1, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC9 citations94
US11104666B2Aug 31, 2021
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC18 citations94
US10899742B1Jan 26, 2021
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC18 citations94
US10844021B2Nov 24, 2020
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC13 citations94
US11952347B2Apr 9, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC3 citations86
US11173211B2Nov 16, 2021
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides
ARVINAS OPERATIONS INC6 citations84
US11065231B2Jul 20, 2021
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
ARVINAS OPERATIONS INC16 citations83
US11964945B2Apr 23, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations73
US11384063B2Jul 12, 2022
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS OPERATIONS INC2 citations73
US11191741B2Dec 7, 2021
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
ARVINAS OPERATIONS INC3 citations73
US11161841B2Nov 2, 2021
Modulators of proteolysis and associated methods of use
ARVINAS OPERATIONS INC3 citations73
US11707452B2Jul 25, 2023
Modulators of alpha-synuclein proteolysis and associated methods of use
ARVINAS OPERATIONS INC2 citations72
US11427548B2Aug 30, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations72
US10994015B2May 4, 2021
EGFR proteolysis targeting chimeric molecules and associated methods of use
ARVINAS OPERATIONS INC3 citations72
US12036209B2Jul 16, 2024
Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides
ARVINAS OPERATIONS INC2 citations70
US11912699B2Feb 27, 2024
Tau-protein targeting compounds and associated
ARVINAS OPERATIONS INC2 citations69
US12577255B2Mar 17, 2026
MDM2-based modulators of proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12552783B2Feb 17, 2026
Modulators of proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12427144B2Sep 30, 2025
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC0 citations62
US12312316B2May 27, 2025
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC0 citations62
US12275716B2Apr 15, 2025
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US12239711B2Mar 4, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations62
US12171831B2Dec 24, 2024
Compounds and methods for the targeted degradation of bromodomain- containing proteins
ARVINAS OPERATIONS INC0 citations62
US12172981B2Dec 24, 2024
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC0 citations62
US11986531B2May 21, 2024
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
ARVINAS OPERATIONS INC0 citations62
US11857519B2Jan 2, 2024
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
ARVINAS OPERATIONS INC0 citations62
US11554171B2Jan 17, 2023
Compounds and methods for the targeted degradation of bromodomain-containing proteins
ARVINAS OPERATIONS INC0 citations62
US10946017B2Mar 16, 2021
Tank-binding kinase-1 PROTACs and associated methods of use
ARVINAS OPERATIONS INC0 citations62
US10865202B2Dec 15, 2020
Indole derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC1 citations62
US12594264B2Apr 7, 2026
Modulators of alpha-synuclein proteolysis and associated methods of use
ARVINAS OPERATIONS INC0 citations61
US12264157B2Apr 1, 2025
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS OPERATIONS INC0 citations61
US11512083B2Nov 29, 2022
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS OPERATIONS INC1 citations61
US10806737B2Oct 20, 2020
Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
ARVINAS OPERATIONS INC2 citations60
US12559486B2Feb 24, 2026
Tau-protein targeting compounds and associated methods of use
ARVINAS OPERATIONS INC0 citations58
US11584743B2Feb 21, 2023
Indole derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC0 citations58
US12208095B2Jan 28, 2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
ARVINAS OPERATIONS INC0 citations54
US12441708B2Oct 14, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations52
US12539292B2Feb 3, 2026
BRM targeting compounds and associated methods of use
ARVINAS OPERATIONS INC0 citations51
ARVINAS INC
8 patentsUS10647698B2May 12, 2020
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS INC31 citations98
US10584101B2Mar 10, 2020
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS INC35 citations97
US10772962B2Sep 15, 2020
Compounds and methods for the targeted degradation of bromodomain-containing proteins
ARVINAS INC15 citations94
US10730870B2Aug 4, 2020
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS INC25 citations93
US10723717B2Jul 28, 2020
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
ARVINAS INC16 citations85
US11352351B2Jun 7, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS INC4 citations73
US10604506B2Mar 31, 2020
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS INC3 citations73
US11458123B2Oct 4, 2022
Tau-protein targeting PROTACs and associated methods of use
ARVINAS INC2 citations71
OSI PHARMACEUTICALS LLC
2 patentsCREW ANDREW P
1 patentAPPARI RAMA DEVI
1 patentShowing the top 50 of 54 patents by PatentIndex Score.